• Title of article

    Identification of Three Novel Mutations in the FANCA, FANCC, and ITGA2B Genes by Whole Exome Sequencing

  • Author/Authors

    Negahdari, Samira Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Zamani, Mina Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Seifi, Tahereh Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Sedighzadeh, Sahar Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Mazaheri, Neda Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Zeighami, Jawaher Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Sedaghat, Alireza Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Saberi, Alihossein Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Hamid, Mohammad Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , keikhaei, Bijan Health Research Institute - Research Centre of Thalassemia and Hemoglobinopathies - Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran , Radpour, Ramin Tumor Immunology - Department for BioMedical Research (DBMR) - University of Bern, Bern, Switzerland , Shariati, Gholamreza Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Galehdari, Hamid Health Research Institute - Research Centre of Thalassemia and Hemoglobinopathies - Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

  • Pages
    7
  • From page
    1
  • To page
    7
  • Abstract
    Background: Various blood diseases are caused by mutations in the FANCA, FANCC, and ITGA2B genes. Exome sequencing is a suitable method for identifying single‑gene disease and genetic heterogeneity complaints. Methods: Among families who were referred to Narges Genetic and PND Laboratory in 2015‑2017, five families with a history of blood diseases were analyzed using the whole exome sequencing (WES) method. Results: We detected two novel mutations (c.190‑2A>G and c.2840C>G) in the FANCA gene, c. 1429dupA mutation in the FANCC gene, and c.1392A>G mutation in the ITGA2B gene. The prediction of variant pathogenicity has been done using bioinformatics tools such as Mutation taster PhD‑SNP and polyphen2 and were confirmed by Sanger sequencing. Conclusions: WES could be as a precise tool for identifying the pathologic variants in affected patient and heterozygous carriers among families. This highly successful technique will remain at the forefront of platelet and blood genomic research.
  • Keywords
    sequence analysis , Fanconi anemia , DNA , congenital abnormalities , Blood platelets
  • Journal title
    International Journal of Preventive Medicine (IJPM)
  • Serial Year
    2020
  • Record number

    2610460